ia4ma: Achieving Global Impact Through a Non-Profit, Independent Association

• Establishing a shared vision and foundation for Managed Access, aligning on ethical principles and industry standards to reduce fragmentation and enable sustainable global pathways
• Delivering value for patients, industry and stakeholders by accelerating equitable access, improving operational efficiency, and enabling meaningful peer and regulatory exchange
• Driving system level impact beyond individual programs by shaping policy, fostering multi stakeholder collaboration, and strengthening global trust in Managed Access

Speakers:

Vilem Guryca

Director, Expanded Access, Global Medical Affairs

BeOne Medicines

Catherine Singfield

Senior Director, Head of EUR/INT Medical, Evidence Optimisation & Managed Access Programmes Team

Jazz Pharmaceuticals plc

Ramona Reichenbach

Head Managed Access & Medical Policy

Novartis AG